In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease

S. Iannaccone, C. Cerami, M. Alessio, V. Garibotto, A. Panzacchi, S. Olivieri, G. Gelsomino, R. M. Moresco, D. Perani

Research output: Contribution to journalArticlepeer-review


Background: Reactive microgliosis, hallmark of neuroinflammation, may contribute to neuronal degeneration, as shown in several neurodegenerative diseases. We in vivo evaluated microglia activation in early dementia with Lewy bodies, still not reported, and compared with early Parkinson's disease, to assess possible differential pathological patterns. Methods: We measured the [11C]-PK11195 binding potentials with Positron Emission Tomography, using a simplified reference tissue model, as marker of microglia activation, and cerebral spinal fluid protein carbonylation levels, as marker of oxidative stress. Six dementia with Lewy bodies and 6 Parkinson's disease patients within a year from the onset, and eleven healthy controls were included. Clinical diagnosis was confirmed at a 4-year follow-up. Results: In dementia with Lewy bodies as well as in Parkinson's disease, we found significant (p <0.001) [11C]-PK11195 binding potential increases in the substantia nigra and putamen. Patients with Lewy bodies dementia had extensive additional microglia activation in several associative cortices. This was evident also at a single subject level. Significant increase of Cerebral Spinal Fluid protein carbonylation was shown in both patients' groups. Conclusions: [11C]-PK11195 Positron Emission Tomography imaging revealed neuroinflammation in dementia with Lewy bodies and Parkinson's disease, mirroring, even at a single subject level, the common and the different topographical distribution of neuropathological changes, yet in the earliest stages of the disease process. Focusing on those events that characterize parkinsonisms and Parkinson's disease may be the key to further advancing the understanding of pathogenesis and to taking these mechanisms forward as a means of defining targets for neuroprotection.

Original languageEnglish
Pages (from-to)47-52
Number of pages6
JournalParkinsonism and Related Disorders
Issue number1
Publication statusPublished - Jan 2013


  • [C]-PK11195
  • Early Parkinson disease
  • Lewy bodies dementia
  • Microglia activation
  • PET

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology
  • Medicine(all)


Dive into the research topics of 'In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease'. Together they form a unique fingerprint.

Cite this